CAY10412 – 50 mg

Brand:
Cayman
CAS:
390824-17-6
Storage:
-20
UN-No:
Excepted Quantity - 1231 / 3

Anandamide (arachidonoyl ethanolamide; AEA) is an endogenous lipid with cannabinergic activity; along with 2-arachidonoyl glycerol, it forms part of the endocannabinoid system.{1134,2713} AEA undergoes reuptake into neurons by a facilitated process.{10647} Controversy exists as to whether there is a specific AEA transporter, or instead the uptake process is simply driven by hydrolysis of AEA by intracellular fatty acyl amide hydrolase (FAAH).{4894,11195} CAY10412 is an analog of AEA that has no intrinsic binding affinity for either CB1 or CB2 receptors.{9623} It is a potent inhibitor of AEA reuptake in U937 lymphoma cells, with an IC50 of 3 µM.{9623} CAY10412 could be a useful tool for distinguishing the competing transporter theories. The pharmacology of CAY10412 is largely unexplored; it may enhance endocannabinoid signalling by augmenting endocannabinoid concentrations.  

 

Available on backorder

SKU: 72620 - 50 mg Category:

Description

An analog of AEA with no intrinsic binding affinity for either CB1 or CB2 receptors; potently inhibits AEA reuptake in U937 lymphoma cells (IC50 = 3 µM); may enhance endocannabinoid signalling by augmenting endocannabinoid concentrations


Formal name: 5Z,8Z,11Z,14Z-eicosatetraenoic acid, 3-theinylmethyl ester

Synonyms: 

Molecular weight: 400.6

CAS: 390824-17-6

Purity: ≥98%

Formulation: A solution in methyl acetate